RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Essex Bio-Technology - Stock

Essex Bio-Technology Equity 2024

Essex Bio-Technology Equity

1.92 B HKD

Ticker

1061.HK

ISIN

KYG312371035

WKN

693609

In 2024, Essex Bio-Technology's equity was 1.92 B HKD, a 11.11% increase from the 1.73 B HKD equity in the previous year.

Essex Bio-Technology Aktienanalyse

What does Essex Bio-Technology do?

Essex Bio-Technology Ltd is a biotechnology company that was founded in Essex, England in 1999. The company specializes in the research and development of innovative products in the healthcare sector, with a focus on the development of vaccines for globally prevalent diseases. Over the years, Essex Bio-Technology Ltd has evolved into a global company operating in Europe, Asia, Africa, and North America. It has offices in the UK, Canada, and China. The company is dedicated to improving the health and well-being of people worldwide, utilizing cutting-edge technology and scientific innovations. Its business model is based on the research, development, and marketing of biotechnology products for the pharmaceutical industry. One of the key areas of focus for Essex Bio-Technology Ltd is the discovery and development of vaccines. The company has made significant progress in particular in the development of vaccines for influenza and tuberculosis. It has also collaborated with other companies in the development of a vaccine for COVID-19. In addition to vaccines, Essex Bio-Technology Ltd has also developed products for medical diagnostics and cancer immunotherapy. These products are used in medical practice and have proven to be extremely successful. Overall, Essex Bio-Technology Ltd has developed an impressive range of products that cover important areas of healthcare. The products are of the highest quality and meet the highest standards in the biotechnology industry. In recent years, the company has established a strong partnership with the pharmaceutical industry. It has conducted collaborative research projects with some of the largest companies in the field to develop new biotechnology products. It has also played a central role in collaboration with governments and non-profit organizations worldwide to ensure that critical medical needs are met. Essex Bio-Technology Ltd stands for the highest quality standards and a commitment to improving healthcare. The company is a leader in biotechnological research and development and has made a name for itself in the pharmaceutical industry. It is a company to be proud of and one that is at the forefront of the journey towards better healthcare for all worldwide. Essex Bio-Technology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Essex Bio-Technology's Equity

Essex Bio-Technology's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Essex Bio-Technology's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Essex Bio-Technology's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Essex Bio-Technology's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Essex Bio-Technology’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Essex Bio-Technology stock

What is the equity of Essex Bio-Technology this year?

Essex Bio-Technology has equity of 1.92 B HKD this year.

What was the equity of Essex Bio-Technology compared to the previous year?

The equity of Essex Bio-Technology has increased/decreased by 11.11% increased compared to the previous year.

What impact does a high equity have on investors of Essex Bio-Technology?

A high equity is advantageous for investors of Essex Bio-Technology as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Essex Bio-Technology?

A low equity can be a risk for investors of Essex Bio-Technology, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Essex Bio-Technology affect the company?

An increase in equity of Essex Bio-Technology can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Essex Bio-Technology affect the company?

A reduction in equity of Essex Bio-Technology can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Essex Bio-Technology?

Some factors that can affect the equity of Essex Bio-Technology include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Essex Bio-Technology so important for investors?

The equity of Essex Bio-Technology is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Essex Bio-Technology take to change the equity?

To change equity, Essex Bio-Technology can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Essex Bio-Technology pay?

Over the past 12 months, Essex Bio-Technology paid a dividend of 0.07 HKD . This corresponds to a dividend yield of about 2.9 %. For the coming 12 months, Essex Bio-Technology is expected to pay a dividend of 0.08 HKD.

What is the dividend yield of Essex Bio-Technology?

The current dividend yield of Essex Bio-Technology is 2.9 %.

When does Essex Bio-Technology pay dividends?

Essex Bio-Technology pays a quarterly dividend. This is distributed in the months of October, July, September, June.

How secure is the dividend of Essex Bio-Technology?

Essex Bio-Technology paid dividends every year for the past 0 years.

What is the dividend of Essex Bio-Technology?

For the upcoming 12 months, dividends amounting to 0.08 HKD are expected. This corresponds to a dividend yield of 3.2 %.

In which sector is Essex Bio-Technology located?

Essex Bio-Technology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Essex Bio-Technology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Essex Bio-Technology from 6/17/2024 amounting to 0.045 HKD, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did Essex Bio-Technology pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of Essex Bio-Technology in the year 2023?

In the year 2023, Essex Bio-Technology distributed 0.095 HKD as dividends.

In which currency does Essex Bio-Technology pay out the dividend?

The dividends of Essex Bio-Technology are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Essex Bio-Technology

Our stock analysis for Essex Bio-Technology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Essex Bio-Technology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.